Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Dihexa is now scheduled for PCAC review before the end of February 2027, alongside four other peptides: LL-37, GHK-Cu, PEG-MGF, and Melanotan II
About this article Cite this article Gonzales-Uribe, A., Ruiz-Cortez, R., Collantes-Silva, N
One of the most controversial is gene therapy designed to program the body to produce its own GLP-1 hormone for years after a single treatment
The MDPI review reports that short sleep duration is associated with increased ghrelin and decreased leptin, hormones involved in hunger and satiety. Together, these findings show that sleep quality and duration influence how the body adapts to a calorie deficit
Luteolin potentiates the sensitivity of colorectal cancer cell lines to oxaliplatin through the PPARgamma/OCTN2 pathway
